Literature DB >> 11861220

Herpes simplex virus.

Travis J Taylor1, Mark A Brockman, Elizabeth E McNamee, David M Knipe.   

Abstract

Herpes simplex virus (HSV) commonly causes human infections in the orofacial region (HSV-1) and in the genital region (HSV-2). Productive viral infection in mucosal epithelial cells may result in clinical symptoms and is followed by a latent infection within sensory neurons. During productive infection a large number of viral gene products are expressed while during latent infection few or no viral proteins are expressed. Reactivation from latency results in recurrent infections and disease at or near the primary site of infection. Understanding the details of the two stages of the HSV life cycle is a particular focus of current research on HSV. The virus interacts with and modifies numerous host cell functions in both epithelial and neuronal cells, and studies of HSV have enhanced our knowledge of many fundamental processes in eukaryotic cells. Ongoing research continues to uncover novel effects of HSV on cells, and a complete understanding of HSV infection during both productive and latent infection should allow the design of new antiviral agents and vaccines and increased knowledge of basic cell and molecular biology. This review article is designed to provide an introduction to HSV biology and key aspects of the infection cycle.

Entities:  

Mesh:

Year:  2002        PMID: 11861220     DOI: 10.2741/taylor

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  53 in total

1.  Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice.

Authors:  Shivaprakash Gangappa; Sharookh B Kapadia; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Reactivation from quiescence does not coincide with a global induction of herpes simplex virus type 1 transactivators.

Authors:  Robert J Danaher; Robert J Jacob; Craig S Miller
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

3.  Live visualization of herpes simplex virus type 1 compartment dynamics.

Authors:  Anna Paula de Oliveira; Daniel L Glauser; Andrea S Laimbacher; Regina Strasser; Elisabeth M Schraner; Peter Wild; Urs Ziegler; Xandra O Breakefield; Mathias Ackermann; Cornel Fraefel
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

4.  In Vitro Replication of Chelonid Herpesvirus 5 in Organotypic Skin Cultures from Hawaiian Green Turtles (Chelonia mydas).

Authors:  Thierry M Work; Julie Dagenais; Tina M Weatherby; George H Balazs; Mathias Ackermann
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

Review 5.  Multiple strategies to improve the therapeutic efficacy of oncolytic herpes simplex virus in the treatment of glioblastoma.

Authors:  Zhengjun Zhou; Junjie Tian; Wenyan Zhang; Wei Xiang; Yang Ming; Ligang Chen; Jie Zhou
Journal:  Oncol Lett       Date:  2021-05-03       Impact factor: 2.967

Review 6.  The role of nanotechnology in the treatment of viral infections.

Authors:  Lavanya Singh; Hendrik G Kruger; Glenn E M Maguire; Thavendran Govender; Raveen Parboosing
Journal:  Ther Adv Infect Dis       Date:  2017-07-05

7.  Determination of Biofilm Initiation on Virus-infected Cells by Bacteria and Fungi.

Authors:  Balbina J Plotkin; Ira M Sigar; Vaibhav Tiwari; Scott Halkyard
Journal:  J Vis Exp       Date:  2016-07-06       Impact factor: 1.355

8.  Cell Cycle-Dependent Expression of Adeno-Associated Virus 2 (AAV2) Rep in Coinfections with Herpes Simplex Virus 1 (HSV-1) Gives Rise to a Mosaic of Cells Replicating either AAV2 or HSV-1.

Authors:  Francesca D Franzoso; Michael Seyffert; Rebecca Vogel; Artur Yakimovich; Bruna de Andrade Pereira; Anita F Meier; Sereina O Sutter; Kurt Tobler; Bernd Vogt; Urs F Greber; Hildegard Büning; Mathias Ackermann; Cornel Fraefel
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

9.  VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis.

Authors:  Todd R Wuest; Daniel J J Carr
Journal:  J Exp Med       Date:  2009-12-21       Impact factor: 14.307

10.  Chemokines and Chemokine Receptors Critical to Host Resistance following Genital Herpes Simplex Virus Type 2 (HSV-2) Infection.

Authors:  M Thapa; D J J Carr
Journal:  Open Immunol J       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.